Also, although the considerations mentioned before are valid for high PSMA expressing PCa lesions, decreasing the MAapp to limit non-specific uptake could also affect the detectability of low PSMA expressing lesions, which could lead to an underestimation of the tumor burden. Here, FOLH1 is linked to neoplasm.